Anderson, Mark S.

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

Bastard, P., Rosen, L. B., Zhang, Q., Michailidis, E., Hoffmann, H.-H., Zhang, Y., Dorgham, K., Philippot, Q., Rosain, J., Béziat, V., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,662

Inborn errors of type I IFN immunity in patients with life-threatening COVID-19

Zhang, Q., Bastard, P., Liu, Z., Le Pen, J., Moncada-Velez, M., Chen, J., Ogishi, M., Sabli, I. K. D., Hodeib, S., Korol, C., et al. (2020) · Science

interferon and immune responsesSARS-CoV-2 and COVID-19 Research

Cited by 2,229

THE NOD MOUSE: A Model of Immune Dysregulation

Anderson, M. S., & Bluestone, J. A. (2005) · Annual Review of Immunology

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 1,113

Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM

Lanz, T. V., Brewer, R. C., Ho, P. P., Moon, J.-S., Jude, K. M., Fernandez, D., Fernandes, R. A., Gomez, A. M., Nadj, G.-S., Bartley, C. M., et al. (2022) · Nature

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 908

Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors

Stamatouli, A. M., Quandt, Z., Perdigoto, A. L., Clark, P. L., Kluger, H., Weiss, S. A., Gettinger, S., Sznol, M., Young, A., Rushakoff, R., et al. (2018) · Diabetes

Cancer Immunotherapy and BiomarkersDiabetes and associated disorders

Cited by 590

Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit

Nadjsombati, M. S., McGinty, J. W., Lyons-Cohen, M. R., Jaffe, J. B., DiPeso, L., Schneider, C., Miller, C. N., Pollack, J. L., Nagana Gowda, G. A., Fontana, M. F., et al. (2018) · Immunity

IL-33, ST2, and ILC PathwaysMast cells and histamine

Cited by 556

Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes

Battaglia, M., Ahmed, S., Anderson, M. S., Atkinson, M. A., Becker, D., Bingley, P. J., Bosi, E., Brusko, T. M., DiMeglio, L. A., Evans-Molina, C., et al. (2020) · Diabetes Care

Diabetes and associated disordersDiabetes Management and Research

Cited by 351

Discovery of stimulation-responsive immune enhancers with CRISPR activation

Simeonov, D. R., Gowen, B. G., Boontanrart, M., Roth, T. L., Gagnon, J. D., Mumbach, M. R., Satpathy, A. T., Lee, Y., Bray, N. L., Chan, A. Y., et al. (2017) · Nature

Genomics and Chromatin DynamicsCRISPR and Genetic Engineering

Cited by 297

Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development

Miller, C. N., Proekt, I., von Moltke, J., Wells, K. L., Rajpurkar, A. R., Wang, H., Rattay, K., Khan, I. S., Metzger, T. C., Pollack, J. L., et al. (2018) · Nature

T-cell and B-cell ImmunologyIon Channels and Receptors

Cited by 289

New frontiers in the treatment of type 1 diabetes

Warshauer, J. T., Bluestone, J. A., & Anderson, M. S. (2020) · Cell Metabolism

Diabetes and associated disordersDiabetes Management and Research

Cited by 259

Thymic regulatory T cells arise via two distinct developmental programs

Owen, D. L., Mahmud, S. A., Sjaastad, L. E., Williams, J. B., Spanier, J. A., Simeonov, D. R., Ruscher, R., Huang, W., Proekt, I., Miller, C. N., et al. (2019) · Nature Immunology

T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

Cited by 225

Aberrant type 1 immunity drives susceptibility to mucosal fungal infections.

Break, T. J., Oikonomou, V., Dutzan, N., Desai, J. V., Swidergall, M., Freiwald, T., Chauss, D., Harrison, O. J., Alejo, J., Williams, D. W., et al. (2021) · Science

Immunodeficiency and Autoimmune DisordersAntifungal resistance and susceptibility

Cited by 175

T cells in the control of organ-specific autoimmunity

Bluestone, J. A., Bour-Jordan, H., Cheng, M., & Anderson, M. (2015) · Journal of Clinical Investigation

T-cell and B-cell ImmunologyImmunotherapy and Immune Responses

Cited by 155

Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled Trial

Russell, W. E., Bundy, B. N., Anderson, M. S., Cooney, L. A., Gitelman, S. E., Goland, R. S., Gottlieb, P. A., Greenbaum, C. J., Haller, M. J., Krischer, J. P., et al. (2023) · Diabetes Care

Diabetes and associated disordersT-cell and B-cell Immunology

Cited by 108

A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells

Van Gool, F., Nguyen, M. L. T., Mumbach, M. R., Satpathy, A. T., Rosenthal, W. L., Giacometti, S., Le, D. T., Liu, W., Brusko, T. M., Anderson, M. S., et al. (2019) · Immunity

T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis

Cited by 102

T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity

Sagan, S. A., Moinfar, Z., Moseley, C. E., Dandekar, R., Spencer, C. M., Verkman, A. S., Ottersen, O. P., Sobel, R. A., Sidney, J., Sette, A., et al. (2023) · Proceedings of the National Academy of Sciences

Multiple Sclerosis Research StudiesT-cell and B-cell Immunology

Cited by 25